Sarita K Jain

Title: Sarita K Jain: Innovator in Neurological Treatments

Introduction

Sarita K Jain is a prominent inventor based in Sunnyvale, CA (US). She has made significant contributions to the field of neurology, particularly in the treatment of progressive supranuclear palsy. Her innovative work has led to the development of a unique pharmaceutical approach that addresses this challenging condition.

Latest Patents

Sarita K Jain holds a patent for a PPARγ agonist for the treatment of progressive supranuclear palsy. The patent details methods of treatment for progressive supranuclear palsy or its symptoms using PPARγ agonists, specifically the compound known as INT 131. The patent outlines methods for selecting subjects with elevated levels of neurofilament light chain protein and administering a therapeutically effective amount of the compound to these individuals.

Career Highlights

Sarita K Jain is currently associated with Coherus Biosciences, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving patient outcomes through innovative therapeutic solutions.

Collaborations

Some of her notable coworkers include Barbara K Finck and David E Weinstein, who contribute to the collaborative environment at Coherus Biosciences, Inc. Their combined expertise enhances the research initiatives within the company.

Conclusion

Sarita K Jain's contributions to the field of neurology through her patent and work at Coherus Biosciences, Inc. highlight her role as a key innovator in developing treatments for progressive supranuclear palsy. Her dedication to advancing medical science is commendable and impactful.